Digging into the Headlines – over 20% weight loss with tirzepatide
The news around the world has been red-hot this week with the publication of the first phase 3...
Read Moreby Dr. Sue Pedersen | Jun 8, 2022 | Media, Research, Uncategorized | 0
The news around the world has been red-hot this week with the publication of the first phase 3...
Read Moreby Dr. Sue Pedersen | Apr 2, 2022 | Media, Uncategorized | 0
Obesity Canada has launched a webinar series called Connected Conversations, hosted by...
Read Moreby Dr. Sue Pedersen | Nov 25, 2021 | Media, Uncategorized | 0
Today brings much excitement in the Canadian obesity treatment landscape: semaglutide 2.4mg...
Read Moreby Dr. Sue Pedersen | Mar 25, 2021 | Media, Uncategorized | 0
As we have clear knowledge that obesity is associated with a higher risk of severe COVID-19...
Read Moreby Dr. Sue Pedersen | Sep 25, 2020 | Diabetes, Media, Uncategorized | 0
Hot off the presses this week are the much anticipated Diabetes Canada Guidelines on medications...
Read Moreby Dr. Sue Pedersen | Aug 30, 2020 | Diabetes, Media, Research, Uncategorized | 0
While the class of medications called SGLT2 inhibitors were originally developed as treatments for...
Read Moreby Dr. Sue Pedersen | Aug 7, 2020 | Bariatrics, Exercise, Media, Uncategorized | 0
As blogged a few days ago, we have now published the 2020 Canadian Adult Obesity Clinical Practice...
Read Moreby Dr. Sue Pedersen | Aug 4, 2020 | Media, Research, Uncategorized | 0
Finally – they are here – three years in the making, the 2020 Canadian Adult Obesity...
Read Moreby Dr. Sue Pedersen | Sep 3, 2018 | Media, Research | 2
Lorcaserin (trade name Belviq) is an obesity medication that is not available in Canada, but is...
Read Moreby Dr. Sue Pedersen | Apr 9, 2018 | Diabetes, Media | 0
The Diabetes Canada (formerly Canadian Diabetes Association) Guidelines are issued in full every 5...
Read Moreby Dr. Sue Pedersen | Feb 5, 2018 | Media | 0
Last week, the Journal of the American Medical Association (JAMA) was rather aggressively...
Read Moreby Dr. Sue Pedersen | Jan 29, 2018 | Diabetes, Media, Research | 0
With any medication, there are benefits and risks that need to be considered. Medications are...
Read MoreI am a medical doctor, Specialist in Endocrinology & Metabolism, and a Diplomate of the American Board of Obesity Medicine. After completing my training as an Endocrinologist in 2005 at the University of Calgary, I have worked in Calgary, at the Royal University Hospital in Saskatchewan, and at the University of Copenhagen in Denmark. I have a busy clinical practice at C-ENDO Diabetes and Endocrinology Clinic in Calgary, caring for patients with diabetes, obesity, thyroid, and other hormone issues. I am also involved in clinical research in diabetes and obesity. I am a member of the Expert Committee for the 2018 Diabetes Canada Guidelines, and lead author of the Pharmacotherapy Chapter of the 2020 Canadian Obesity Guidelines. I am passionate, enthusiastic, and driven to help conquer the stigma against obesity; educate health care professionals and the public about obesity, diabetes, and healthy living; and to help us become a healthier society!
Thank you for visiting my website.